Search research articles
Contact Us
Filters
Showing results (21-30 of 199) with videos related to
Page
of 20
Sort By:
Bulletin Du Cancer
|
February 27, 2025
[Mirvetuximab soravtansine as monotherapy in platinum-resistant ovarian cancer expressing alpha folate receptor]
Mathilde Reich, Manuel Rodrigues
Bulletin Du Cancer
|
March 16, 2024
[Dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer]
Charles Raynaud, Manuel Rodrigues
Bulletin Du Cancer
|
June 7, 2022
[New drug approval: Pembrolizumab plus lenvatinib in second line for patients with advanced or recurrent endometrial cancer]
Clara De Jesus, Manuel Rodrigues
Bulletin Du Cancer
|
November 10, 2022
[New drug approval: Tebentafusp for treatment of metastatic uveal melanoma HLA A*02:01-positive patients]
Antoine Gaillard, Alexandre Matet, Manuel Rodrigues
Bulletin Du Cancer
|
February 26, 2021
[Pembrolizumab as first-line therapy in microsatellite instability metastatic colorectal cancers]
Dimitri Pureur, Manuel Rodrigues, Anthony Turpin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 18, 2012
On the prevalence and causes of oncologist burnout
Pierre Blanchard, Manuel Rodrigues, Philippe Colombat
Bulletin Du Cancer
|
November 10, 2022
[New drug arrival : Pembrolizumab as second-line treatment in MSI-H/dMMR endometrial, colorectal, gastric, intestinal and biliary cancers]
Nathan El-Ghazzi, Benoit Rousseau, Manuel Rodrigues
Bulletin Du Cancer
|
February 10, 2018
[The place of cancer's cure in the personalized medicine and immunotherapy]
Cecile Torregrosa, Manuel Rodrigues, Marie-France Mamzer-Bruneel
Acta Otorrinolaringologica Espanola
|
January 12, 2010
Lingual thyroid: an accidental finding
Marta Neves, Paula Azevedo, Manuel Rodrigues e Rodrigues
Bulletin Du Cancer
|
August 21, 2025
[TRANSFORM-O: A new training program in translational research offered by the French Society of Cancer (SFC) and the French National College of Oncology Teachers (CNEC)]
Stanislas Quesada, Camille Tlemsani, Christophe Massard, et al.
Page
of 20
Search research articles
Search
Showing results (21-30 of 199) with videos related to
Sort By:
Page
of 20
Bulletin Du Cancer
|
February 27, 2025
[Mirvetuximab soravtansine as monotherapy in platinum-resistant ovarian cancer expressing alpha folate receptor]
Mathilde Reich, Manuel Rodrigues
Bulletin Du Cancer
|
March 16, 2024
[Dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer]
Charles Raynaud, Manuel Rodrigues
Bulletin Du Cancer
|
June 7, 2022
[New drug approval: Pembrolizumab plus lenvatinib in second line for patients with advanced or recurrent endometrial cancer]
Clara De Jesus, Manuel Rodrigues
Bulletin Du Cancer
|
November 10, 2022
[New drug approval: Tebentafusp for treatment of metastatic uveal melanoma HLA A*02:01-positive patients]
Antoine Gaillard, Alexandre Matet, Manuel Rodrigues
Bulletin Du Cancer
|
February 26, 2021
[Pembrolizumab as first-line therapy in microsatellite instability metastatic colorectal cancers]
Dimitri Pureur, Manuel Rodrigues, Anthony Turpin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 18, 2012
On the prevalence and causes of oncologist burnout
Pierre Blanchard, Manuel Rodrigues, Philippe Colombat
Bulletin Du Cancer
|
November 10, 2022
[New drug arrival : Pembrolizumab as second-line treatment in MSI-H/dMMR endometrial, colorectal, gastric, intestinal and biliary cancers]
Nathan El-Ghazzi, Benoit Rousseau, Manuel Rodrigues
Bulletin Du Cancer
|
February 10, 2018
[The place of cancer's cure in the personalized medicine and immunotherapy]
Cecile Torregrosa, Manuel Rodrigues, Marie-France Mamzer-Bruneel
Acta Otorrinolaringologica Espanola
|
January 12, 2010
Lingual thyroid: an accidental finding
Marta Neves, Paula Azevedo, Manuel Rodrigues e Rodrigues
Bulletin Du Cancer
|
August 21, 2025
[TRANSFORM-O: A new training program in translational research offered by the French Society of Cancer (SFC) and the French National College of Oncology Teachers (CNEC)]
Stanislas Quesada, Camille Tlemsani, Christophe Massard, et al.
Page
of 20